Erik K.

Erik K. is an experienced investment professional currently serving as an Investment Manager at CCRM since November 2017, focusing on preclinical-stage companies in cell, gene therapies, and regenerative medicine. Prior roles include Senior Associate, Senior Investment Analyst, and Investment Analyst at Jaqar Corporate Strategy, specializing in M&A advisory and financial modeling. Erik has also held positions as an Investor Relations Analyst at EZTEC, where successful investor relations efforts led to multiple awards, and as a Trading Desk Intern at Macquarie Group, developing hedging strategies for commodities. Earlier experience includes a role as an Investor Relations Intern at Gafisa, supporting investor communications. Erik holds a Master's of Finance from Queen's University and a Bachelor's degree in Economics from USP, with additional CFA Level 1 specialization in Finance.